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M I C R O B I O L O G Y
Niche partitioning of a pathogenic microbiome driven 
by chemical gradients
Robert A. Quinn1,2*, William Comstock1, Tianyu Zhang3, James T. Morton4, Ricardo da Silva1,  
Alda Tran1, Alexander Aksenov1,2, Louis-Felix Nothias1, Daniel Wangpraseurt5,6, Alexey V. Melnik1,  
Gail Ackermann7, Douglas Conrad8, Isaac Klapper9, Rob Knight2,4,7, Pieter C. Dorrestein1,2,7*
Environmental microbial communities are stratified by chemical gradients that shape the structure and function 
of these systems. Similar chemical gradients exist in the human body, but how they influence these microbial 
systems is more poorly understood. Understanding these effects can be particularly important for dysbiotic shifts 
in microbiome structure that are often associated with disease. We show that pH and oxygen strongly partition 
the microbial community from a diseased human lung into two mutually exclusive communities of pathogens 
and anaerobes. Antimicrobial treatment disrupted this chemical partitioning, causing complex death, survival, and 
resistance outcomes that were highly dependent on the individual microorganism and on community stratification. 
These effects were mathematically modeled, enabling a predictive understanding of this complex polymicrobial 
system. Harnessing the power of these chemical gradients could be a drug-free method of shaping microbial com-
munities in the human body from undesirable dysbiotic states.
INTRODUCTION
Since the time of Sergei Winogradsky (c. 1880s), environmental micro-
biologists have shown that chemical parameters, such as pH, oxygen, 
and redox state, shape the structure and function of microbial com-
munities (1, 2). Chemical gradients create unique niche spaces that 
can be colonized by particular microbes, resulting in a stratified micro-
bial ecosystem that responds uniquely to environmental change (3, 4). 
Microbial communities that cause chronic infections of the human 
airway, skin, gut, and other organs or surfaces are not too dissimilar 
in their responses to these factors from those found in the environ-
ment, but how chemical gradients shape the niche partitioning and 
physiology in an infectious context has not been extensively investi-
gated. Instead, research has focused on identifying virulence mecha-
nisms of individual bacterial pathogens within the community. For 
example, although the cystic fibrosis (CF) lung microbiome has been 
extensively characterized (5) and virulence mechanisms of its principle 
pathogens have been studied for decades (6, 7), little is known about 
what drives community interactions associated with disease (5, 8).
The importance of chemical gradients in shaping human microbial 
communities has become particularly pertinent in CF lung disease. 
Microenvironments are known to exist in different regions of the lung, 
resulting in microbial and chemical heterogeneity (9), and various 
chemical gradients have been measured in vivo (10, 11). Recently, a 
study of the microbial ecology of the CF microbiome showed that a 
shift in community physiology to anaerobic fermentation occurred 
during acute flares of CF disease called pulmonary exacerbations 
(CFPEs) (12). CFPEs are a detrimental event in the lives of CF pa-
tients contributing significantly to their morbidity and mortality, but 
they have a poorly understood etiology (13, 14). The Climax and 
Attack model of CF microbial ecology proposes that there are two 
distinct microbial communities in the CF lung that are dynamically 
changing during CFPEs (15, 16). The subsequent observation of 
microbial physiology changes associated with these events led to the 
hypothesis that chemical gradients may play a role in the dynamics 
of the lung microbiome. Therefore, in this study, we explore com-
petition outcomes between constituents of the CF microbiome in 
chemical gradients using an experimental microcosm of a mucus- 
plugged bronchiole called the WinCF system (12). WinCF is based on 
the Winogradsky column [a century-old method for studying micro-
bial communities in soil and sediment (2, 17)]. Principles of the 
Winogradsky column are maintained, including the ability to obtain 
visual and quantitative output of microbial behavior through chemical 
gradients, but WinCF is unique in that it contains media mimicking 
lung mucus in a thin cylindrical tube that is similar in diameter to 
lung bronchioles (18). Here, we show that pH and oxygen gradients 
strongly partition the CF microbiome into two communities favoring 
opposing niche space. These gradients govern competition outcomes 
between community constituents, have effects on death and resistance 
to antimicrobial therapy, and can be harnessed to predictably manipu-
late the community with support from mathematical modeling.
RESULTS
Microbial community changes in WinCF pH gradients
To test the effects of pH on the CF microbiome, sputum samples 
from patients (n = 18; table S1) were grown in a WinCF pH gradient 
from 5.0 to 8.5 (fig. S1). The artificial sputum medium (ASM) used 
for the WinCF media was buffered to a gradient of pH, and sputum 
was mixed with the media before inoculation via capillary action 
into the WinCF columns. Phenol red and bromocresol purple dyes 
were added to monitor the initial pH gradient and any changes due 
to growth. Growth of the sputum microbiome resulted in the pro-
duction of gas bubbles and changing of the medium pH from its initial 
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starting point (Fig. 1, A and B). Gas production, an indicator of micro-
bial fermentation in WinCF (12), occurred in all columns and was 
most abundant at pH 6.5 (Fig. 1A) but was reduced at elevated pH 
[P < 0.05, analysis of variance (ANOVA); table S2 and Fig. 1A]. For 
the CF samples, the gas bubble production at pH 8.0 and 8.5 was 
significantly lower than at pH 5.5, 6.0, and 6.5 (one-way ANOVA, P < 
0.05; Fig. 1 and table S2). Quantitation of changes in the WinCF pH 
indicator dyes enabled an assessment of the influence of the initial pH 
gradient on subsequent culture pH after growth. At the two highest 
pH starting points, the WinCF pH indicator dye did not change, demon-
strating that, when the CF microbiome was grown in high pH, it main-
tained that pH, which is a trend not evident in control samples (Fig. 1B 
and table S2). Therefore, as described above, low gas production was 
associated with the maintenance of a high-pH environment (Fig. 1, A 
and B, and table S2).
Microbial community sequencing of the WinCF tubes using 16S 
rRNA gene amplification allowed for an assessment of the taxa asso-
ciated with these chemically induced changes. The high-pH and low–
gas production community had a less diverse microbiome (Fig. 1C), and 
accordingly, there was a positive correlation between microbial diversity 
and gas production (Pearson’s r = 0.475, P < 0.001). Microbes asso-
ciated with high gas production included Veillonella, Streptococcus, 
Prevotella, Atopobium, and Bulledia, a consortium previously shown 
to co-occur in vivo (16). A random forests (RF) linear model was used 
to determine whether the microbiome data were reflecting the pH 
of the initial starting culture. This model was able to accurately predict 
the starting pH on the basis of the microbiome data, thus indicating 
that the pH gradient had a highly significant effect on the community 
structure (Fig. 2A and fig. S2). This finding was verified by the balance 
trees approach to niche partitioning in microbiome data, which ac-
counts for challenges with data compositionality (fig. S3, A to C) (19). 
The most diverse community was present at pH 6.5, whereas the pH 
extremes were occupied by fewer taxa, particularly higher pH (fig. 
S3, B and C). To determine the effects of pH on particular bacterial 
genera, we applied a generalized linear mixed model (GLMM) to test 
the distribution of the most abundant microbes through the pH gradient. 
Pseudomonas (P = 0.02), Haemophilus (P < 0.0001), Achromobacter 
(P = 0.0001), and the anaerobe Fusobacterium (P < 0.0001) were posi-
tively correlated with increasing pH, whereas the anaerobic genera 
Veillonella (P < 0.0001), Prevotella (P < 0.0001), Actinomyces (P < 
0.0001), and Streptococcus (P < 0.0001) were strongly negatively cor-
related (Fig. 2B). Thus, the diverse low-pH community was primarily 
composed of fermentative anaerobes commonly observed in micro-
biome profiles from CF sputum. In contrast, the high-pH group com-
prised facultative anaerobes and organisms more commonly considered 
pathogenic. RF linear models and GLMM were also used to identify 
microbes associated with elevated gas production. Again, the commu-
nity was partitioned into anaerobes associated with high gas production 
and pathogens with low gas production (Supplementary Materials). 
Thus, the pH gradient markedly altered the physiology and diversity of 
the CF microbiome, revealing the presence of two physiologically 
different communities in the sputum samples: one, a low-diversity 
community of microorganisms that when placed in a high-pH envi-
ronment maintained that high pH and did not ferment, and the 
other, a high- diversity community of bacteria that lowered the pH of 
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Fig. 1. WinCF microbial physiology and diversity changes in response to pH and oxygen gradients. Boxplots of the amount of gas produced (A), change in green color 
saturation (B), and Shannon-Weiner diversity index (C)  in the WinCF capillary columns through the pH gradient in both CF and non-CF sputum samples. Letters above the boxplot 
denote significant differences between the 8 and 8.5 pH samples. (D) Boxplot of the Shannon-Weiner index at each millimeter depth through the WinCF capillary columns 
with and without bicarbonate treatment. Sputum samples are shown as a reference when applicable. ***P < 0.001, **P < 0.01, *P < 0.05 from Mann-Whitney U test.
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Microbial community changes in WinCF oxygen gradients
An oxygen microelectrode showed that the WinCF columns contained 
steep oxygen gradients similar to those measured in the lung (10) and 
sputum (fig. S4) (11). This enabled analysis of the CF microbiome 
through an oxygen gradient similar to the pH experiments, by first 
gelling the media and sectioning the WinCF cultures into 1-mm sec-
tions from 1- to 10-mm depth after the growth of the sputum samples 
(n = 19; figs. S1 and S5). Although an RF linear model showed that 
the microbial community was strongly shaped by depth, there was 
little change after 6 mm (Fig. 2C). Microbial community diversity 
increased with increasing vertical depth (Pearson’s r = 0.472; Fig. 1D), 
mirroring the results of the pH experiments, where the chemical 
gradient partitioned the community into low diversity and high di-
versity. The CF community separated into microbes with a niche in 
the upper layers of the mucus (1 to 4 mm), the middle layers of the 
mucus (4 to 7 mm), and the deepest layers of the mucus (7 to 10 mm; 
fig. S3, E and F). The genera were normally distributed around a depth 
of 4.5 mm, with few bacteria exclusively preferring the aerobic layers 
(1 to 2 mm). Pseudomonas was especially affected by the oxygen gra-
dient, being strongly negatively correlated with depth (P < 0.0001; 
Fig. 2D). Many anaerobes increased their relative abundance with 
depth including Streptococcus (P < 0.0001), Prevotella (P = 0.006), 
Veillonella (P < 0.0001), Fusobacterium (P = 0.03), and the facultative 
anaerobe Haemophilus (P = 0.002; Fig. 2D).
To assess the combined effect of pH and oxygen on the CF micro-
biome, we added bicarbonate to the aerobic interface of the WinCF 
columns. HCO3− was added to the top of the media to mimic the 
inhaled therapy of this ion, which is being developed as a treatment 
for CF to alleviate its decreased transport in the lung epithelium (20). 
Bicarbonate further decreased the community diversity, but only in 
the 2-, 3-, and 4-mm depths (P < 0.05, Mann-Whitney U test; Fig. 1D). 
The heightened effect of the pH and oxygen in combination demon-
strates the potential to manipulate a polymicrobial infection with 
simple chemistry.
Metabolite production changes in chemical gradients
The chemical gradients also affected community physiology as determined 
by tandem liquid chromatography–mass spectrometry (LC-MS/MS) 
and gas chromatography–mass spectrometry (GC-MS) metabolomics. 
The metabolomes were highly affected by the pH, gas production, and 
oxygen variables (fig. S2). One of the most strongly affected meta-
bolites was a by-product of microbial tryptophan metabolism: in-
doleacetate. This molecule was positively correlated to gas production 
(LMM, P < 0.0001; table S3) and associated with a Streptococcus OTU 
(Spearman’s  = 0.775), Bulledia moorei ( = 0.694), and Prevotella 
melaninogenica ( = 0.581). We detected the short-chain fatty acids 
(SCFAs) acetic acid, propionic acid, and butyric acid in both the 
WinCF and sputum samples, indicating that the culture system in-
duced similar metabolic activity to that in vivo. Propionic acid was 
positively correlated with gas production (LMM, P < 0.0001) and 
anaerobes (Supplementary Materials), but  negatively correlated with 
pH (P < 0.0001) and Pseudomonas (Pearson’s r = −0.416, P < 0.001). 
Butyric acid was positively correlated with pH (P = 0.005). Acetic acid 
was not correlated with either variable.
Pseudomonas aeruginosa produces a variety of specialized me-
tabolites, many of which act as antimicrobials and virulence factors, 
including quinolones, phenazines, rhamnolipids, and the siderophore 
pyochelin (Fig. 3, fig. S6, and table S4). Production of these molecules 
was also influenced by the chemical gradients. Phenazine-1-carboxylic 
acid (PCA) was positively correlated with pH (P = 0.0005) and pyocy-
anin (PYO; P = 0.01), and the rhamnolipid Rha-Rha-C10-C10 (P = 0.01) 
were negatively correlated with gas production. The oxygen gradient 
markedly altered the production of these virulence factors, as they all 
decreased in abundance through the WinCF column depth, but some 
were more strongly affected than others (Fig. 3 and table S4). An LMM 
showed that the most strongly affected metabolites were 2-nonyl- 4-
hydroxyquinolone (NHQ; P < 0.0001), PYO (P < 0.0001), PCA (P = 
0.0001), pyochelin (P < 0.0001), Rha-Rha-C10-C10 (P < 0.0001), 2-heptyl- 
4-hydroxyquinolone-N-oxide (P = 0.0003), 2-heptyl-4-hydroxyquinolone 
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Fig. 2. Effect of pH and oxygen gradients on microbial community in WinCF system. RF linear models (A and C) and bacterial genus distributions (B and D) in the 
WinCF pH and oxygen experiments. An RF linear model was run on the (A) pH and (C) depth of each 16S rDNA microbiome profile from the WinCF experiments. The 
model predicts the pH or depth of a sample on the basis of the microbiome data, providing a measure of the strength of the overall microbial changes through the gradients. 
The percent variance of the data in the model is also shown. The distributions of bacterial genera of interest are visualized for pH (B) and oxygen (D) using a visual depiction 
of the WinCF system experiments generated with the ‘ili software (45). The color scale for each WinCF tube represents the relative abundance of that particular operational 
taxonomic unit (OTU) and is shown for each panel, as they are not all at the same scale. In the oxygen experiment, each layer represents 1 mm into the WinCF media, and in the 
pH experiment, each column represents the WinCF columns grown in the pH gradient with 0.5 units from 5 to 8.5. The normalized abundance of bacterial genera of in-
terest are shown as a heat map, with red being the most abundant and blue being the least abundant. The P value from the LMM for each genus in each gradient is shown.
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(HHQ; P = 0.0003), and 2-heptyl-3-hydroxy-4-quinolone (PQS; P = 
0.0003; Fig. 3). PQS was most abundant in the first two oxic milli-
meters and dropped in abundance drastically with depth, reflecting 
its association with molecular oxygen (21). Phenazines, which are 
redox-active antibiotics produced by P. aeruginosa and many other 
bacteria (22), were depleted in the anoxic layers, although PCA was 
less affected than PYO. PYO was also less abundant when gas pro-
duction was highest in the pH experiments.
Effects of inhaled therapies on a chemically stratified 
microbial community
Because of the strong impact of chemical gradients on the CF micro-
biome, we attempted to determine whether the stratification would 
affect the results of inhaled CF treatments. Sodium bicarbonate and 
the anti-Pseudomonas antibiotic tobramycin were added to the top 
of the culture in separate WinCF columns (n = 19) before growth 
to simulate inhalation into an airway with mucus-plugged bronchioles. 
Bicarbonate increased Pseudomonas abundance in the aerobic and 
microaerophillic layers and decreased the abundance of Veillonella 
(Fig. 4 and fig. S7). Tobramycin induced drastic changes in the micro-
bial community structure through the oxygen gradient. The antibiotic 
killed Pseudomonas and Veillonella in all regions of the column. 
Streptococcus was killed in the oxic layers but survived below a depth 
of 5 mm, while Prevotella bloomed below this depth. Stenotrophomonas 
thrived in the presence of tobramycin, and reads mapping to the mito-
chondrion of the fungus Aspergillus were also detected in the oxic 
layers (Fig. 4). Thus, tobramycin inhibited the growth of many bac-
teria normally found in the upper layers of the mucus and left niche 
space for resistant organisms to flourish. Many anaerobes survived 
in the deeper anoxic layers of the mucus because the antibiotic ex-
isted in a gradient of concentration unable to reach them at depth 
(verified in LC-MS/MS data; fig. S8). This shows that the inherent 
community stratification due to the effects of oxygen had a profound 
effect on the tobramycin treatment (fig. S7). This phenomenon cre-
ates the potential for the development of resistance due to lower drug 
concentrations deeper in lung mucus.
Unexpectedly, tobramycin was of very low abundance after com-
munity growth compared to controls and undetectable in 15 of the 
19 patients’ WinCF columns. Evidence of propionylation in the metabo-
lomics data indicates that this scarcity was due to aminoglycoside 
modifying enzymes from CF bacteria changing the molecule (23). 
Although various acetylations have been reported on tobramycin as 
a mechanism of inactivation (23), in our data, we only detected the 
uncommon propionylation of the middle saccharide of tobramycin 
(fig. S9) (24). Thus, tobramycin that was directly added to the 
WinCF columns was being altered by the CF microbiome through 
aminoglycoside-modifying enzymes. Other modifications were likely 




































































































































































































































































































































Fig. 3. Molecular networks of P. aeruginosa virulence factors and their abundance through depth in the WinCF columns. The data are mapped onto a model of the 
WinCF oxygen experiment using the ‘ili software (45). The log mean intensity of each P. aeruginosa virulence metabolite through the 1- to 10-mm-depth sections of the 
WinCF media is shown as a heat map with the oxygen penetration shown for reference. The Pearson’s r value of the correlation with depth is shown as well as the P value 
from the LMM. Plots of the log area under the curve compared to depth in the WinCF media are shown colored by each patient for each metabolite of interest. The mo-
lecular networks show the metabolites of interest and their related molecules. Each node represents a unique MS/MS spectrum from the molecular networking algorithm, 
and edges between the nodes represent a cosine similarity between them above 0.7. Colors of the nodes are scaled to their abundance in the oxic layer of the WinCF 
columns (1 mm) in spectral counts, and the node size is scaled to the overall abundance of the metabolite. Structures and mass in daltons of each virulence metabolite 
are shown. HQNO, 2-heptyl-4-hydroxyquinolone-N-oxide.
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the specific mechanisms of this metabolism remain unknown. When 
intact tobramycin was detected and in high abundance, it corresponded 
to samples that contained Aspergillus in the oxic layers (r = 0.577, P < 
0.001; Fig. 5, A and B), and in these same samples, metabolites from 
Aspergillus fumigatus were detected (Fig. 5C and fig. S10). The abun-
dance of these metabolites through the WinCF gradient matched the 
relative abundance of Aspergillus mitochondrion reads. Collectively, 
these experiments show the complexity of the microbial response to 
antibiotic treatments, which include resistance mechanisms and com-
plex death and survival responses for individual microbes.
Predictive mathematical modeling of CF microbiome  
in chemical gradients
The predictability of the anaerobe and pathogen response in the WinCF 
columns enabled mathematical modeling of their behavior through 
pH and oxygen gradients and a determination of its most significant 
drivers. Modeling allows testing, in a simplified setting without con-
founding factors, of hypotheses relating chemical and community 
structures that are not easily assayed in the laboratory. The model 
includes two microbial communities, P. aeruginosa and fermentative 
anaerobes, with their populations denoted by p and f, respectively. 
Physiological parameters in the model are sourced from literature 
describing P. aeruginosa’s behavior in the CF lung (see Supplementary 
Materials). The pathogen is facultatively anaerobic, raises the pH of 
its environment, and produces antimicrobial metabolites. Fermenters 
consume sugar, produce acid, and are killed by oxygen (12, 25). In 
accordance with our experimental results, the contours of f and p, 
when all quantities reached steady state, show that the growth of fer-
menters was restricted to the anaerobic region and was better in the 
low–initial pH case (Fig. 6A). P. aeruginosa had limited growth in 
low pH but thrived in the aerobic region in high pH. Thus, at different 
mucus pH, the carrying capacity of a mucus-plugged bronchiole for 
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Fig. 4. The 3D models of the WinCF oxygen experiments with treatment visualized using the ‘ili software (45). Each column represents the WinCF medium that is 
sectioned in 1-mm depths. The sections are colored according to the normalized abundance of bacterial genera of interest. The untreated samples (NT), bicarbonate 
(BC)–treated samples, and tobramycin (TB)–treated samples are shown, as well as the LMM P values with and without the depth as a mixed effect. NS, not significant.
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either P. aeruginosa or fermentative anaerobes is starkly different. 
This matched the experimental results and supports the mutually 
exclusive dynamic between anaerobes and P. aeruginosa observed in 
other studies (12, 16). Removal of P. aeruginosa’s pH dependence or pro-
duction of antimicrobial factors from the model revealed that these 
parameters were crucial for the results observed (Fig. 6, B and C). 
Thus, the strong niche partitioning from the pH experiments may be 
due to a favored pH range for each organism. Each bacterium alone can 
grow in a wider range of pH, but when in competition with others, the 
community strongly partitioned. Incorporating bicarbonate and tobra-
mycin treatments into the model mirrored our experimental results. 
Bicarbonate raises the pH of the environment, causing P. aeruginosa to 
bloom, with little effect on the anaerobes (Fig. 6, D and E). Tobramycin 
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Fig. 5. Profiles of Aspergillus mitochondrion reads, tobramycin abundance, and Aspergillus specialized metabolite abundance through the WinCF oxygen gradients in 
the 19 patients tested in this study. (A) Relative abundance of 16S rDNA gene reads in each patient mapping to the Aspergillus mitochondrion in tobramycin-treated 
WinCF tubes through the 10-mm depth. (B) Summed ion intensity of tobramycin in each patient through the WinCF 10-mm depth treated with tobramycin. (C) Spectral 
counts of A. fumigatus specialized metabolites in same samples.
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DISCUSSION
Antibiotic treatment regimens against polymicrobial infections target 
pathogens cultured from clinical samples. This approach is naïve 
to the fact that these pathogens are only a single member of a com-
plex community, and treatment outcomes are complicated by spe-
cies interactions and the chemical conditions that shape them. Here, 
we demonstrate that a pathogenic community from the human airway 
is structured in a laboratory microcosm by pH and oxygen gradients, 
which are chemical conditions commonly encountered in chronic 
infections. These gradients affect community metabolism, virulence 
factor production, treatment, and resistance. Similar chemical gra-
dients are believed to structure the human gut microbiome during 
health and disease (26), suggesting that the influence of this chemis-
try is centrally relevant in other organ systems. This finding mirrors 
the basic dogma of environmental microbiology that chemical gra-
dients drive the ecology and physiology of microbial communities in 
soil, sediment, and other microbial ecosystems.
pH and oxygen gradients partitioned the CF microbiome into two 
mutually exclusive and fundamentally different microbial commu-
nities: a diverse community of fermentative anaerobes preferring lower 
pH and anoxia and a nonfermentative group of classic pathogens pre-
ferring high pH and high oxygen. This partitioning was consistent 
across individuals despite each patient having a unique microbiome. 
These two communities represent those of the Climax and Attack 
model of CF microbial ecology proposed to be important to pulmonary 
exacerbations (15, 16). Recent studies have identified signatures of 
microbial fermentation and the expansion of anaerobes during CFPEs 
(12, 27, 28). This study shows that the lung microbiome can be shifted 
to favor a fermentative community through lowering pH and decreas-
ing oxygen. The dominance of anaerobic bacteria in a low-oxygen 
mucus environment was somewhat surprising because P. aeruginosa 
is known to flourish in anaerobic environments by nitrate reduction 
in vitro and in vivo (29, 30). In the WinCF tubes, P. aeruginosa growth 
by denitrification was outcompeted by anaerobes, even when nitrate 
was available in the WinCF medium (31). Thus, a chemically driven 
dysbiosis that favors anaerobic fermentation may explain the domi-
nance of these organisms during exacerbations and the sometimes 
extremely low pH values measured in CF sputum (11, 12, 28). Al-
though the causes of CFPE remain mostly unknown, they continue 
to be a serious clinical problem facing physicians. Chemical shifts 
that favor fermentation and acid production could result in a positive 
feedback loop, further favoring an anaerobe-dominated community 
and a further drop in pH. Strong community shifts may be the underly-
ing cause of CFPEs, but further research is needed to confirm this 
possibility and to determine whether microbial community changes 
are a consequence of a developing CFPE or its fundamental cause. An 
important context for this study is the fact that, although the WinCF 
system is meant to mimic a CF bronchiole, it does not contain host cells 
or components of the inflammatory response that also shape the make-
up and physiology of the CF microbiome. Further research into the role 
that lower lung pH has on both the microbial community and the host 






















































































































































































































































































































Fermenters θp Pseudomonas θf Fermenters θp Pseudomonas θf Fermenters
D Eθp Pseudomonas θf Fermenters
BC NT TB
Fig. 6. Results of mathematical model simulations on the CF microbiome response to pH. (A) Contours of P. aeruginosa p and the fermentative anaerobe f growth 
in the WinCF capillary column environment when started at low or high pH. The aerobic portion of the column is at the top of the figure, and the anaerobic portions are 
at the bottom. Depth, width, and intensity of growth parameters are on unitless scales. (B) Contours of p and f given by the simulation with the effect of inhibition 
chemical I turned off (set 1 = 0 in the model); therefore, in this case, P. aeruginosa has no effect on the growth of fermenters. (C) Contours of p and f with the effect pH 
on the growth of P. aeruginosa turned off (set 2 = 0 in the model). In this case, there is no difference between the low and high initial pH as expected. Contours of (D) p 
and (E) f resulting from the simulated treatment of bicarbonate (BC) and tobramycin (TB) from the top portion of the media are compared to the untreated case (NT). 
These results demonstrate the predictability of the community response to inhaled CF treatments.
Quinn et al., Sci. Adv. 2018; 4 : eaau1908     26 September 2018
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
8 of 12
The chemical gradients also altered aspects of community metabo-
lism through the production of indoles and organic acids. In the 
case of the latter, lowering lung mucus pH favored anaerobic fermen-
tation and the production of propionic acid. In the lung, this could 
contribute to a further decrease in the airway surface liquid pH and the 
low pH of sputum observed in other studies (11). P. aeruginosa has 
been shown to feed on propionic acid produced by anaerobes in vitro 
and express genes for its metabolism in vivo (25). The bacterium’s 
negative correlation with this SCFA may therefore be due to its metabo-
lism of this compound during cross-feeding with anaerobes (25). Cross- 
feeding in such a system may further connect the Climax and Attack 
communities and potentially worsen lung infections if P. aeruginosa 
is stimulated by the by-products of anaerobic fermentation (27).
Small-molecule virulence factors from P. aeruginosa were also altered 
by the chemical gradients. Phenazines, quinolones, rhamnolipids, and 
the siderophore pyochelin all decreased with depth in the WinCF tubes. 
While this effect is not unexpected considering the decreased abun-
dance of P. aeruginosa in the anoxic layers, some metabolites were more 
strongly affected than others. The P. aeruginosa quorum- sensing metab-
olite PQS was highly abundant in the oxic layers (1 to 2 mm) and 
then quickly depleted. This pattern likely reflects the requirement of 
molecular oxygen for its synthesis (21) and explains its absence in 
LC-MS/MS profiles of CF sputum (33). HHQ, NHQ, and PCA, how-
ever, reached far into the anoxic mucus layers, where P. aeruginosa 
itself was not detected. This finding demonstrates that some viru-
lence metabolites and quorum-sensing molecules from the bacterium 
can readily diffuse through a mucus-filled environment, while others 
are more static. PYO was depleted in the anoxic layers and less abundant 
when gas production was highest in the pH experiments. This indicates 
that PYO production, believed to be important for P. aeruginosa’s 
competitive advantage in the CF lung, is diminished or inhibited when 
grown in competition with anaerobic bacteria. The altered production 
of virulence metabolites through oxygen and pH gradients shows that 
the action of these molecules, including their inhibitory effect on host 
and microbial cells (34, 35), may be overwhelmed by simple changes 
in oxygen and pH and through competition with other bacteria in the 
airway.
Particularly relevant to clinical treatments against CF infections, 
chemical gradients altered antibiotic treatment outcomes against patho-
gens in the WinCF lung-bronchiole model system. Simulated tobra-
mycin treatment drastically altered the community structure. The 
drug killed aerobically growing Pseudomonas in the upper layers, a 
physiological susceptibility that has been previously described (36), 
but surprisingly, tobramycin also induced a bloom of Stenotrophomonas 
and the fungus Aspergillus in its place. Stenotrophomonas maltophilia 
is highly resistant to tobramycin (37) and many other antibiotics 
(38). These experiments show that inhalation of tobramycin may in-
duce a bloom of resistant S. maltophilia and possibly contribute to 
the increasing prevalence of this pathogen in CF patients (38). The 
effect of tobramycin on the growth of Aspergillus, a common aerobic 
fungal pathogen (39), was particularly remarkable. It demonstrates 
that antibiotic treatment aimed at killing bacterial pathogens may 
have unwanted consequences, including the growth of other more 
resistant pathogens and fungi. Furthermore, the inherent stratifica-
tion of the CF microbiome induced by oxygen had a direct effect on 
tobramycin treatment. Many anaerobes, including Prevotella and 
Streptococcus, survived, but only in the deeper anoxic layers of the 
mucus because the antibiotic existed in a gradient of concentration 
unable to reach them at depth. This phenomenon also creates the 
potential for the development of resistance as the limited drug pen-
etration results in lower concentrations deeper in the mucus. Further 
work on the interaction between tobramycin, Aspergillus spp., and 
CF bacteria (40) is needed to better understand the dynamics of this 
inhaled treatment in CF lungs. Collectively, these results demonstrate 
that, because of the oxygen stratification of the community, antibiotic 
treatment against bacterial pathogens can have complex and poten-
tially undesirable consequences. These consequences include the growth 
of more resistant bacteria, the survival of species with anaerobic niche 
space, the development of unique mechanisms of resistance, and the 
growth of fungi that replace the niche previously occupied by the tar-
geted pathogen, the latter being a phenomenon observed in vivo (41).
Because of the strong effects of pH and oxygen gradients observed 
in this study, we attempted to manipulate the CF microbiome in a 
predictable manner by simulating inhaled bicarbonate treatment that 
has a direct effect on lung pH. In clinical trials to treat consequences 
of cystic fibrosis transmembrane conductance regulator (CFTR) 
dysfunction, bicarbonate lowered community diversity by inducing 
a P. aeruginosa bloom. This mimicked the effect of our initial pH 
experiment that showed that the pathogen favors a high-pH niche 
space. This effect only occurred in the microaerophillic regions of 
the WinCF tubes, indicating that inherent effects of oxygen stratifi-
cation also impart an effect on pH manipulation. This led to our 
attempt to mathematically model the CF microbiome competitive 
interactions in this environment and how they are affected by these 
treatments. Our model validated the hypothesis that P. aeruginosa 
and fermentative anaerobes partition into separate communities driven 
by the initial mucus pH, oxygen, and products of their separate me-
tabolisms. The model showed that at extremes of mucus pH the carry-
ing capacity of a mucus-plugged bronchiole for either P. aeruginosa 
or fermentative anaerobes is starkly different. At high initial pH, 
P. aeruginosa dominates the aerobic portion of the tubes, but at low 
initial pH, fermentative anaerobes thrive, but only in the anaerobic 
regions. This finding was mirrored in our experimental results and 
supports the mutually exclusive dynamic between anaerobes and 
P. aeruginosa observed in other studies (12, 16). Mechanisms within 
the model were then iteratively removed to determine which were 
the most responsible for the community partitioning. P. aeruginosa’s 
inherent preference for a higher pH and its production of antimicrobi-
al factors were crucial for the experimental results observed. Thus, 
these two factors should be further explored when investigating the 
dynamics surrounding this pathogen and anaerobic bacteria in CF 
lungs, especially as it relates to exacerbations. Collectively, the re-
sults of our bicarbonate experiments and mathematical modeling 
show that care should be taken when developing this compound as an 
inhaled therapy for CF due to the potential for P. aeruginosa stimu-
lation. However, inhaled bicarbonate in combination with antibiot-
ics such as tobramycin may be an advantageous means of selecting 
for the growth of P. aeruginosa, enabling the antibiotic to more effec-
tively kill it. Combinatorial therapies that pair the manipulative 
power of basic chemistry, such as pH and oxygen, with targeted 
antimicrobials may be a novel approach to antimicrobial therapy 
allowing for more targeted killing on the basis of a fundamental 
understanding of the microbial ecology of a system.
In sum, these experiments show that the same chemical influences 
long known to govern microbial community structure in environ-
mental systems also strongly shape microbial communities in the 
human body. The effect of pH and oxygen gradients on microbial com-
munity structure has direct implications for competition outcomes, 
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virulence factor production, antibiotic treatment efficacy, and resistance. 
It may be possible to take advantage of the overwhelming influence 
of these simple chemical parameters to manipulate a pathogenic or 
dysbiotic microbiome to an appropriate state that enables more tar-




Samples were collected from the University of California San Diego 
(UCSD) adult CF clinic during routine visits from patients. Sputum 
samples were expectorated into a sputum cup and transported back to 
the laboratory within 3 hours of collection. All samples were collected 
via the UCSD institutional review board–approved protocol for human 
subject research (project #160078). A total of 18 sputum samples 
were collected from CF patients for the pH experiments and another 
19 for the oxygen experiments (table S1). In addition, six sputum samples 
were collected from healthy volunteers after saline mouth rinse and ex-
pectoration of airway mucus as a comparison for the pH experiments. 
Samples were split into four aliquots: one fresh for WinCF culturing 
and three aliquots frozen at −80°C for 16S ribosomal RNA (rRNA) 
gene sequencing and LC-MS/MS and GC-MS metabolomics.
WinCF chemistry experiments
For the pH experiments, ASM was prepared according to (12, 42) 
and then split into eight different stocks that were buffered to a pH 
gradient from 5 to 8.5 (0.5 pH unit intervals) with a phosphate buffer 
concentration of 50 mM. The desired pH for each interval was achieved 
by adding the appropriate amount of monosodium phosphate and 
disodium phosphate and then bringing the media to the appropriate 
pH using HCl or NaOH. The pH dyes phenol red and bromocresol 
purple were added to the media to aid in pH gradient visualization 
(fig. S1A). After homogenization, 50 l of each sputum sample was 
inoculated into 250 l of ASM media at eight different pH intervals 
within 6 hours of sample collection. This mixture was vortexed and 
inoculated into capillary columns (nonheparinized Fisherbrand and 
Microhematocrit capillary columns, Fisher Scientific) in triplicate, 
as described in (12). All WinCF columns were incubated at 37°C for 
48 hours, and then the medium from each triplicate capillary column 
was removed and pooled. Three separate 50-l aliquots of this pooled 
mixture were then prepared for 16S rRNA gene sequencing and metabo-
lomics analysis of nonvolatile compounds using LC-MS/MS and vola-
tiles using GC-MS. The oxygen experiments were done using the same 
medium formulation, but a 0.5% agar solution was mixed with the me-
dium before inoculation (fig. S1B). The WinCF columns were created 
by drawing the warm molten media and agar into a 1000-l pipette tip, 
sealing the pointed end while leaving the wide end open to the air 
and allowing it to cool. Three columns were created for each of the 
19 sputum samples acquired, the first left untreated, the second treated 
with 20 l of tobramycin (60 mg/ml), and the third being treated with 
20 l of 7% sodium bicarbonate. The treatments were added to the 
top open portion of the columns before incubation. Control columns 
with no sputum were generated and analyzed in the same manner. 
The columns were incubated as described above. After incubation, 
they were frozen at −80°C and sectioned with a sterile razorblade in 
1-mm sections to analyze the microbial and chemical difference through 
a 10-mm depth using a sterile razorblade. The sections were stored in 
microcentrifuge columns. For 16S rDNA sequencing, 200 l of 1× 
phosphate-buffered saline was added to each column. Extractions for 
metabolomics were done directly on the sectioned media. Further 
details for both procedures are available in Supplementary Methods.
16S rRNA gene sequencing
The microbiome of both the sputum samples and the media from 
the WinCF columns after incubation in the pH and oxygen experi-
ments were analyzed using 16S rRNA gene amplicon sequencing. 
For the sputum samples, an aliquot of the sample was frozen 
at −80°C before sequencing in batch with all other samples. DNA 
extraction, 16S rRNA gene variable region 4 (V4) polymerase chain 
reaction, and amplicon preparation for sequencing were performed 
according to protocols benchmarked for the Earth Microbiome Project 
found here http://www.earthmicrobiome.org/protocols-and-standards/ 
(see Supplementary Methods).
Metabolomics
For LC-MS/MS analysis, metabolites from both the sputum and 
WinCF media from the pH and oxygen experiments were extracted 
using a successive ethyl acetate and methanol extraction procedure 
as outlined in (33). The metabolite extracts were then diluted four-
fold in methanol containing 2 M glycocholic acid or ampicillin 
(Fisher Scientific) used as an MS internal standard. The chromato-
graphic separation was conducted on a ThermoScientific UltiMate 
3000 Dionex UPLC system (Fisher Scientific) with eluent further 
analyzed on a Bruker Daltonics MaXis qTOF mass spectrometer 
(Bruker). Metabolites were separated using a Kinetex 2.6-m C18 
(30 × 2.10 mm) UPLC column. Ratios of water and acetonitrile for 
mobile phases A and B (98:2 and 2:98, respectively) containing 0.1% 
formic acid and a linear gradient from 0 to 100% for a total run time 
of 840 s at a flow rate of 0.5 ml min−1 were used. For further details 
see Supplementary Methods.
The GC-MS analysis for the pH samples was conducted via head-
space sampling with a polydimethylsiloxane/divinylbenzene (PDMS/
DVB) df 65-m solid-phase microextraction (SPME) fiber. A Thermo 
Scientific TRACE 1310 GC [TG-5ms 5; length, 30 m; ID (inner 
diameter) , 0.25 mm; film thickness column, 0.25 m] and a TSQ 8000 
EVO mass spectrometer (Thermo Fisher Scientific), equipped with 
electron ionization (EI) source, were used for the analysis. The frozen 
samples were transferred into 1.5-ml borosilicate glass vials, capped 
with silicon septum cap, placed onto tray of the GC-MS instrument, 
and allowed to thaw. The PDMS/DVB SPME (Supelco) tip was in-
serted by the sampling robot into the vial, and the sample was heated 
to 160°C and agitated for 10 min. Upon sample extraction, the SPME 
was inserted into the GC inlet maintained at 250°C, and the extracted 
compounds were desorbed for 1 min, cryofocused at −10°C on the 
head of the column, and then analyzed with a gas chromatographic 
protocol outlined in Supplementary Methods.
Data processing
Sequencing data were prepared and analyzed using the online tool Qiita 
(https://qiita.ucsd.edu/). The data were processed with the Deblur 
algorithm to identify unique taxa in the 16S rDNA amplicons (43). 
The taxonomic information was collapsed to the genus level for all 
statistical analyses except regressions between metabolites and bac-
terial abundance that were analyzed at the deblurred OTU level.
The Bruker LC-MS/MS.d data files were converted to .mzXML 
format and uploaded to the Global Natural Products Social Molecular 
Networking database for molecular networking and spectral annotation 
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[GNPS; (http://gnps.ucsd.edu) (44)]. Molecular network were gen-
erated using the following parameters: parent and fragment tolerance 
of 0.2 Da (fragment tolerance of 0.5 Da for oxygen experiment), four 
minimum matched fragment ions to create a cluster node, minimum 
cosine score of 0.7, and a minimum cluster size of 2. The GNPS li-
braries were searched using a minimum cosine of 0.7 and minimum 
matched fragment ions of 4. Molecular networks were visualized using 
the Cytoscape software v3.3.0. Annotations from GNPS were shaped 
as arrowheads in the network to distinguish them from other nodes. The 
sizes of the nodes were scaled to the total ion count of the cluster. Edges 
in the network were created using the cosine score between two nodes, 
and the thickness of the edge was scaled to that value. Links to the pH 
network and oxygen networks are found here: pH (http://gnps.ucsd.edu/
ProteoSAFe/status.jsp?task=1974c72bc4bf414faa1f5a3330e648ab) 
and oxygen (http://gnps.ucsd.edu/ProteoSAFe/status.jsp?task= 
34d825dbf4e9466e81d809faf814995b). The MS1-based feature detec-
tion for metabolite abundance estimation in the pH experiments was 
performed using the Knime OpenMS workflow using Optimus soft-
ware (https://github.com/MolecularCartography/Optimus) (see Sup-
plementary Methods for details). Metabolite annotations based on 
MS/MS library matches GNPS were linked to the MS1 features using 
the mass/charge ratio and retention time. Column blank samples and 
internal standard blanks were included in the Optimus run to remove 
background contaminant peaks from the data.
The GC-MS data were analyzed using the Thermo Scientific 
Trace Finder software (Thermo Fisher Scientific). The samples with 
the most diverse peak count were screened for metabolites of interest. 
Peaks of these metabolites were found and integrated using ICIS inte-
gration algorithm with peak threshold of 1% of largest peak. The Na-
tional Institute of Standards and Technology (NIST) 2014 EI library 
was used to perform spectral matches with forward and reverse search. 
Known background contaminants (such as siloxanes and phthalates) 
were removed from targeted list of molecules, and 37 compounds of 
interest were selected. Batch mode with the developed method was used 
to find and integrate all targeted compounds. In addition, the abun-
dances of specific metabolites of interest (acetic acid, propionic acid, and 
butyric acid) were manually calculated using the area under the curve 
feature of Thermo Xcalibur QualBrowser software (Thermo Fisher 
Scientific) to validate quantification of these targeted metabolites.
Statistical analysis
The microbiome OTU table for all samples was used to calculate 
the Shannon diversity index. Samples were rarefied to 1000 reads 
per sample before statistical analysis. Diversity calculations were 
done using the vegan package in the R statistical software. Regres-
sions between diversity measures and WinCF variables were carried 
out using Pearson’s r. The RF algorithm was used to develop both 
a classification and linear model of both the metabolome and 
microbiome data based on the linear variables of the capillary 
columns and by sample type. RF analyses were carried out using the 
randomForest package in R with 5000 trees. Variable importance 
plots were used to identify OTUs and metabolites that were most 
correlated to the linear variables.
A generalized linear mixed-effects model (GLMM) was applied to 
model the relationship between bacterial sequence counts (at the genus 
level) as the dependent variable and pH and depth as the independent 
variables. The GLMM model accounts for non-normal distribution of 
data and to assign a random effect to individual (patient), as data were 
gathered over time on the same individuals with differing microbial 
sputum profiles. To model metabolite intensity as the dependent vari-
able and pH and depth variables as independent, a standard linear 
mixed-effects model (LMM) was used. The R packages MASS and 
nlme were used to perform the modeling.
Balance trees were used to assess the effect of the gradients and 
gas production on the WinCF model microbiome at the taxonomic 
level of genera. Balances represent the log ratios of groups of microbes 
mitigating many of the issues associated with compositionally (19). 
The 16S rRNA gene sequencing data from the pH experiment were 
used to help develop the balance tree method and have been previ-
ously published (19). Here, we have built two trees, one to charac-
terize the pH gradient, where microbes are split according to where 
they are most abundant along the pH gradient and another to charac-
terize effects of the oxygen gradient. Balances were computed from 
these trees via the isometric log-ratio transformation using Gneiss 
(19). Two different LMMs were run on these balances to test for dif-
ferences in pH and depth while accounting for the patient-specific 
differences.
Data visualization
The ‘ili software (http://ili.embl.de/) was used to visualize microbial 
and metabolite changes through the pH and oxygen gradients. 3D.stl 
models of the WinCF columns and its 1-mm sections for the oxygen 
experiment and the eight capillary columns from the pH experiment 
were created using the GeoMagic Wrap software. The location of each 
sample in the.stl file was recorded using the x, y, and z coordinates 
from GeoMagic Wrap. The normalized abundance of OTUs or me-
tabolites from the multiomics data was mapped on to the appropriate 
sample locations in the WinCF columns using the corresponding x, y, 
and z coordinates from the.stl file in the ‘ili software to help visualize 
the microbial and chemical changes in the context of the experimental 
design. Additional information on materials and methods is avail-
able in the Supplementary Materials.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
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Fig. S1. Schematic of the experimental design with the WinCF system modified for the pH 
experiments and the oxygen experiments.
Fig. S2. Actual measurement versus predicted value from RF machine learning algorithm on 
the microbiome and metabolome data through pH, gas production, and depth variables.
Fig. S3. Niche partitioning of CF lung microbiota in the pH and oxygen experiments.
Fig. S4. O2 microenvironment (% air saturation) through the WinCF vertical depth gradient 
after incubation with sputum from two patients compared to a noninoculated control.
Fig. S5. Microbiome profiles of individual patients in the pH and oxygen experiments.
Fig. S6. Molecular network of rhamnolipids and quinolones detected in the LC-MS/MS data.
Fig. S7. GLMM results for different bacterial genera on a per patient basis.
Fig. S8. Mean abundance of tobramycin by ion count in the WinCF columns after incubation.
Fig. S9. Tobramycin and N-propionyl tobramycin identification from polar LC-MS/MS data.
Fig. S10. A. fumigatus metabolites in tobramycin-treated WinCF columns.
Fig. S11. Mean abundance of pooled anaerobes in the WinCF columns after the different treatments.
Fig. S12. WinCF model equations.
Fig. S13. Principle co-ordinate analysis (PCoA) plots of metabolome and microbiome data from 
all samples.
Table S1. Patient samples and information collected in this study.
Table S2. ANOVA of qualitative and quantitative variables measured during the WinCF pH 
gradient experiments.
Table S3. Metabolites that most changed with the WinCF gas production gradient according 
to an RF variable importance plot from the untreated samples.
Table S4. Mean abundance through the depth gradient (1 to 10 mm) of P. aeruginosa virulence 
factor metabolites detected in the WinCF depth experiments and the corresponding Pearson’s 
correlation (r).
Table S5. Deblurred OTUs and their sequences that most changed with the WinCF depth 
gradient according to an RF variable importance plot from the untreated samples.
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